CompletedNot Applicable

Bright IDEAS - Young Adults Problem-Solving Skills Training

United States344 participantsStarted 2021-02-10

Plain-language summary

The purpose of this project is to evaluate efficacy of Bright IDEAS, an evidence-based problem-solving skills training (PSST) program, as a supportive care intervention for young adult (YA) cancer patients compared with enhanced usual psychosocial care with 344 young adult patients newly diagnosed with cancer.

Who can participate

Age range

18 Years – 39 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Current age 18-39 * Within 4 months of first diagnosis of any cancer * Cancer being treated with chemotherapy and/or radiation therapy and/or hematopoietic stem cell transplant * No documented or self-reported cognitive delay or impairment that would prevent completion of survey measures * English-speaking Exclusion Criteria: * Medical crisis or not receiving curative therapy per physician/treatment team report * Treatment involves surgery only

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Change in Symptoms of Depression, as Measured by the Patient-Reported Outcomes Measurement Information System (PROMIS) Depression Short-Form (v1.0 8a)

Timeframe: From Baseline to Time 3 (about 6 months from baseline)

Change in Symptoms of Anxiety, as Measured by the PROMIS Anxiety Short-Form (v1.0 8a)

Timeframe: From Baseline to Time 3 (about 6 months from baseline)

Change in Functional Assessment of Cancer Therapy - General (FACT-G v4)

Timeframe: From Baseline to Time 3 (about 6 months from baseline)

Trial details

NCT IDNCT04585269

SponsorRutgers, The State University of New Jersey

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-09-29

Results submitted2025-09-25

View on ClinicalTrials.gov More Cancer Patients trials

Plain-language summary

Who can participate

Age range

18 Years – 39 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

Change in Symptoms of Depression, as Measured by the Patient-Reported Outcomes Measurement Information System (PROMIS) Depression Short-Form (v1.0 8a)

Timeframe: From Baseline to Time 3 (about 6 months from baseline)

Change in Symptoms of Anxiety, as Measured by the PROMIS Anxiety Short-Form (v1.0 8a)

Timeframe: From Baseline to Time 3 (about 6 months from baseline)

Change in Functional Assessment of Cancer Therapy - General (FACT-G v4)

Timeframe: From Baseline to Time 3 (about 6 months from baseline)